|
Synonyms: QR-110 | QR110
Compound class:
Nucleic acid
Comment: Sepofarsen (QR-110) is an antisense oligonucleotide (ASO) [2] that is an exon-skipping agent for a specific intronic variant of the gene for centrosomal protein CEP290 (c.2991+1655A>G) in photoreceptor cells that is causative in the rare ocular condition Leber congenital amaurosis 10 [1,3]. Sepofarsen is proposed to promote synthesis of functional CEP290 protein.
|
| No information available. |
Summary of Clinical Use ![]() |
| Sepofarsen (QR-110) was progressed as a clinical candidate for potential to treat Leber congenital amaurosis 10. This therapeutic is delivered intravitreally. |
| Clinical Trials | |||||
| Clinical Trial ID | Title | Type | Source | Comment | References |
| NCT06891443 | Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION) | Phase 3 Interventional | Laboratoires Thea | ||
| NCT03913143 | A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE) | Phase 2/Phase 3 Interventional | ProQR Therapeutics | ||